Compass Therapeutics Chief Accounting Officer Neil Lerner acquires 2,500 common shares worth $2,850
CMPX•Compass Therapeutics Chief Accounting Officer Neil Lerner purchased 2,500 common shares at $1.14 each, worth $2,850. His beneficial ownership rose to 400,000 shares.
1. Share purchase
Neil Lerner reported purchasing 2,500 Compass Therapeutics common shares at $1.14 each, bringing his beneficial ownership to 400,000 shares.
